Diet & Nutrition
U.S. FDA warns consumers about danger of "dietary supplements" promoted for sexual enhancement
Published in Medical Letter on the CDC and FDA, August 20th, 2006
These products are promoted and sold on web sites as "dietary supplements" for treating erectile dysfunction (ED) and enhancing sexual performance, but they are in fact illegal drugs that contain potentially harmful undeclared ingredients. These products have not been approved by FDA, and there is no guarantee of their safety and effectiveness, or of the purity of their ingredients.
FDA advises consumers who have used any of these products to discontinue use and to consult their health care...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Outbreaks
Marburg virus was linked to large hemorrhagic fever outbreak in Angola - Rotavirus Epidemiology
Rotavirus results in significant number of hospitalizations in U.S. - Streptococcus Genetics & Genomics
Streptococci from children in Nepal share genetic relatedness with isolates from other countries - Virology
Real-time quantitative PCR assays to detect virus-specific DNA have been developed - Addiction Medicine
Severity of Dependence Scale indicates cannabis dependence in adolescents - Alcohol Use
Gabapentin does not alter effects of alcohol - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
